|Tale of Woe |
Merck gives back five-year gains...
|...after fall 2004's plunge|
Already, Merck has lost nearly $35 billion in market value as a result of the Vioxx scandal. The company's stock has traded in the low $30s since the news emerged. Near the end of 2000 -- Vioxx's first full year on the market -- Merck stock fetched more than $80 a share.